Our Blog

Sienna Cancer Diagnostics (ASX:SDX) capital raising

16 Dec 2019 – Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company’s capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.


Source: Finance News Network

Share this post